A Trial of Upadacitinib for Non-responsive Eosinophilic Esophagitis

NCT07588568 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

52

Enrollment

OTHER

Sponsor class

Conditions

EoE
Eosinophilic Esophagitis
Eosinophilic Esophagitis (EoE)

Interventions

DRUG: Upadacitinib 30mg Dose
OTHER: Upadacitinib Matching Placebo

Sponsor

University of North Carolina, Chapel Hill

Collaborators

[object Object]
[object Object]